| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | -82.3% |
| R&D Expense | $8.6M | +16.8% |
| SG&A Expense | $3.8M | -24.7% |
| Operating Income | -$10.4M | -797.9% |
| Pre-tax Income | -$9.6M | — |
| Income Tax | $200 | -70.6% |
| Net Income | -$9.6M | — |
| EPS (Basic) | -$1.77 | — |
| EPS (Diluted) | -$1.69 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -16.1% |
| Current Assets | $16.9M | -24.4% |
| Total Assets | $17.0M | -24.5% |
| Current Liabilities | $2.5M | +67.1% |
| Total Liabilities | $2.5M | +67.1% |
| Stockholders' Equity | $14.5M | -31.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -699.3% |
| Capital Expenditures | $90K | +0.0% |
| Investing Cash Flow | $5.9M | +140.8% |
| Financing Cash Flow | $2.9M | +1270.8% |
| Free Cash Flow | -$9.9M | -651.2% |